|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the CVS 8-K filed Nov 2, 2006. Section 16 Matters. Prior to the Effective Time, each party shall take all such steps as may be required to cause any
dispositions of Caremark Stock (including derivative securities with respect to Caremark Stock) or acquisitions of CVS Stock (including derivative securities with respect to CVS Stock) resulting from the transactions contemplated by Article 2 of
this Agreement by each individual who is subject to the reporting requirements of Section 16(a) of the 1934 Act with respect to Caremark will become subject to such reporting requirements with respect to CVS, to be exempt under Rule 16b-3
promulgated under the 1934 Act.
Section 8.14 This excerpt taken from the CVS DEFA14A filed Nov 2, 2006. Section 16 Matters. Prior to the Effective Time, each party shall take all such steps as may be required to cause any
dispositions of Caremark Stock (including derivative securities with respect to Caremark Stock) or acquisitions of CVS Stock (including derivative securities with respect to CVS Stock) resulting from the transactions contemplated by Article 2 of
this Agreement by each individual who is subject to the reporting requirements of Section 16(a) of the 1934 Act with respect to Caremark will become subject to such reporting requirements with respect to CVS, to be exempt under Rule 16b-3
promulgated under the 1934 Act.
Section 8.14 | EXCERPTS ON THIS PAGE:
RELATED TOPICS for CVS: |
| |||||||